JC

Jaydeep Chanda

Director Director DIN 02612973
DIN 02612973 First appointment Apr 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaydeep Chanda

Data last updated:

Jaydeep Chanda was a Director at Edico Labs Private Limited (2011) and Director at Nicon Biogenics Private Limited (from 2009). The companies operate in Pharma.

DIN 02612973
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Edico Labs Private Limited U24232RJ2011PTC035325
Director27 May 20112011₹27.7 Lakh (FY 2022)Active
Nicon Biogenics Private Limited U24230GJ2009PTC056676
Director20 Apr 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nicon Biogenics Private Limited
Edico Labs Private Limited
Premium access

Shareholding and investment profile for Jaydeep Chanda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaydeep Chanda

Jaydeep Chanda was first appointed on 20 Apr 2009 as Director at Nicon Biogenics Private Limited. The most recent appointment on record is 27 May 2011 at Edico Labs Private Limited.

Jaydeep Chanda held 2 earlier board appointments: Edico Labs Private Limited (Director, 27 May 2011 to 15 Nov 2011); Nicon Biogenics Private Limited (Director, from 20 Apr 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available